13 May 2014 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) has told manufacturers of OTC oral healthcare products containing benzocaine that product labelling can include a warning about methemoglobinemia.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.